INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Systematic review / meta-analysis / 2012

Chocolate, cocoa, and flavan-3-ols improved flow-mediated dilatation, insulin resistance, and diastolic blood pressure in a meta-analysis of randomized trials.

A systematic review and meta-analysis of 42 RCTs involving 1,297 participants assessed the cardiovascular effects of chocolate, cocoa, and flavan-3-ols. Intake improved HOMA-IR (-0.67; 95% CI: -0.98, -0.36) via reductions in serum insulin, and enhanced FMD after chronic (1.34%; 95% CI: 1.00%, 1.68%) and acute (3.19%; 95% CI: 2.04%, 4.33%) intake. Reductions were seen in diastolic blood pressure (-1.60 mm Hg; 95% CI: -2.77, -0.43 mm Hg) and mean arterial pressure (-1.64 mm Hg; 95% CI: -3.27, -0.01 mm Hg). Evidence quality was low to moderate according to GRADE due to unclear reporting of allocation concealment, dropouts, missing outcome data, and biomarker heterogeneity.

Study type
Systematic review and meta-analysis of randomized controlled trials
Who was studied
1,297 participants across 42 acute or short-term chronic (≤18 weeks) RCTs
What was measured
Insulin resistance (HOMA-IR), flow-mediated dilatation (FMD), blood pressure, and lipid profiles

THE PAPER

Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis of randomized trials.

Hooper L, Kay C, Abdelhamid A, Kroon PA, Cohn JS, Rimm EB, Cassidy A. Am J Clin Nutr, 2012.

PubMed 22301923 ↗DOI 10.3945/ajcn.111.023457 ↗

Heart & arteriesDiabetes & blood sugarBlood pressure

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.